Description
With thyroid eye disease (TED), the goal of today’s treatment is to preserve vision, as well as reduce symptoms. Current therapies are not truly disease-modifying. HCPs feel frustrated that they can’t act sooner to stop the longer-term consequences of TED, or offer their patients something better for improved QoL.